Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229454595> ?p ?o ?g. }
- W4229454595 endingPage "108783" @default.
- W4229454595 startingPage "108783" @default.
- W4229454595 abstract "The rapid development of bioengineering technology has introduced Fc-fusion proteins, representing a novel kind of recombinant protein, as promising biopharmaceutical products in tumor therapy. Numerous related anti-tumor Fc-fusion proteins have been investigated and are in different stages of development. Fc-fusion proteins are constructed by fusing the Fc-region of the antibody with functional proteins or peptides. They retain the bioactivity of the latter and partial properties of the former. This structural and functional advantage makes Fc-fusion proteins an effective tool in tumor immunotherapy, especially for the recruitment and activation of natural killer (NK) cells, which play a critical role in tumor immunotherapy. Even though tumor cells have developed mechanisms to circumvent the cytotoxic effect of NK cells or induce defective NK cells, Fc-fusion proteins have been proven to effectively activate NK cells to kill tumor cells in different ways, such as antibody-dependent cell-mediated cytotoxicity (ADCC), activate NK cells in different ways in order to promote killing of tumor cells. In this review, we focus on NK cell-based immunity for cancers and current research progress of the Fc-fusion proteins for anti-tumor therapy by activating NK cells." @default.
- W4229454595 created "2022-05-11" @default.
- W4229454595 creator A5003642180 @default.
- W4229454595 creator A5004374561 @default.
- W4229454595 creator A5007626139 @default.
- W4229454595 creator A5007789490 @default.
- W4229454595 creator A5016679112 @default.
- W4229454595 creator A5018339408 @default.
- W4229454595 creator A5021984184 @default.
- W4229454595 creator A5029762841 @default.
- W4229454595 creator A5035585059 @default.
- W4229454595 creator A5047914292 @default.
- W4229454595 creator A5052556650 @default.
- W4229454595 creator A5053118577 @default.
- W4229454595 creator A5054235059 @default.
- W4229454595 creator A5062251557 @default.
- W4229454595 creator A5071558018 @default.
- W4229454595 creator A5077597150 @default.
- W4229454595 creator A5082328851 @default.
- W4229454595 creator A5084063375 @default.
- W4229454595 date "2022-08-01" @default.
- W4229454595 modified "2023-10-17" @default.
- W4229454595 title "Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy" @default.
- W4229454595 cites W101392706 @default.
- W4229454595 cites W1487745522 @default.
- W4229454595 cites W1490976899 @default.
- W4229454595 cites W1491394604 @default.
- W4229454595 cites W1493742659 @default.
- W4229454595 cites W1508110130 @default.
- W4229454595 cites W1527985047 @default.
- W4229454595 cites W1528349069 @default.
- W4229454595 cites W1538902372 @default.
- W4229454595 cites W1595098530 @default.
- W4229454595 cites W1603913234 @default.
- W4229454595 cites W1606776565 @default.
- W4229454595 cites W1788305820 @default.
- W4229454595 cites W1813394859 @default.
- W4229454595 cites W1814788217 @default.
- W4229454595 cites W1830427486 @default.
- W4229454595 cites W1845250843 @default.
- W4229454595 cites W1903287340 @default.
- W4229454595 cites W1917682458 @default.
- W4229454595 cites W1936300843 @default.
- W4229454595 cites W1938215938 @default.
- W4229454595 cites W1967397018 @default.
- W4229454595 cites W1969814796 @default.
- W4229454595 cites W1969950463 @default.
- W4229454595 cites W1970431511 @default.
- W4229454595 cites W1970880147 @default.
- W4229454595 cites W1976732997 @default.
- W4229454595 cites W1979281121 @default.
- W4229454595 cites W1979428884 @default.
- W4229454595 cites W1980725734 @default.
- W4229454595 cites W1981054482 @default.
- W4229454595 cites W1983768225 @default.
- W4229454595 cites W1984580814 @default.
- W4229454595 cites W1985102822 @default.
- W4229454595 cites W1987562611 @default.
- W4229454595 cites W1989407795 @default.
- W4229454595 cites W1989712520 @default.
- W4229454595 cites W1990974720 @default.
- W4229454595 cites W1992886596 @default.
- W4229454595 cites W1993309708 @default.
- W4229454595 cites W1993575340 @default.
- W4229454595 cites W1994447535 @default.
- W4229454595 cites W1994953238 @default.
- W4229454595 cites W1996195426 @default.
- W4229454595 cites W1996891899 @default.
- W4229454595 cites W1998162097 @default.
- W4229454595 cites W1998189366 @default.
- W4229454595 cites W1999191024 @default.
- W4229454595 cites W2000260992 @default.
- W4229454595 cites W2001239531 @default.
- W4229454595 cites W2002595222 @default.
- W4229454595 cites W2005765588 @default.
- W4229454595 cites W2006245117 @default.
- W4229454595 cites W2017567560 @default.
- W4229454595 cites W2018311806 @default.
- W4229454595 cites W2019686157 @default.
- W4229454595 cites W2021377837 @default.
- W4229454595 cites W2021439199 @default.
- W4229454595 cites W2022066424 @default.
- W4229454595 cites W2024579897 @default.
- W4229454595 cites W2025161447 @default.
- W4229454595 cites W2025629542 @default.
- W4229454595 cites W2027268124 @default.
- W4229454595 cites W2028046471 @default.
- W4229454595 cites W2030019925 @default.
- W4229454595 cites W2031782624 @default.
- W4229454595 cites W2032463003 @default.
- W4229454595 cites W2032492606 @default.
- W4229454595 cites W2033107431 @default.
- W4229454595 cites W2034408745 @default.
- W4229454595 cites W2034515273 @default.
- W4229454595 cites W2034694119 @default.
- W4229454595 cites W2039638023 @default.
- W4229454595 cites W2039691173 @default.
- W4229454595 cites W2041953257 @default.